Related Experiment Video
Updated: Jul 29, 2026
06:44
Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain
Published on: June 23, 2009
Recalcitrant vulvodynia. A clinicopathological study
E W Sonnendecker1, H E Sonnendecker, C A Wright
1Department of Obstetrics and Gynaecology, University of the Witwatersrand, Johannesburg.
Summary
Human papillomavirus (HPV) is a key factor in burning vulva syndrome, affecting 77% of analyzed patients. While treatments show promise, vulvodynia remains a complex, multifactorial condition with persistent challenges.
Area of Science:
- Gynecology
- Dermatology
- Infectious Diseases
Background:
- Burning vulva syndrome often presents with subtle physical findings, necessitating specific diagnostic procedures.
- Vulvodynia is a complex condition with multifactorial causes, impacting patient quality of life.
Purpose of the Study:
- To analyze the causes and characteristics of burning vulva syndrome in a cohort of 26 women.
- To investigate the role of human papillomavirus (HPV) and other conditions in vulvodynia.
Main Methods:
- Colposcopically directed biopsy and acetic acid application were used for diagnosis.
- Histopathological examination was performed to identify characteristic features of HPV infection.
- Patient data was analyzed to identify associated conditions and treatment outcomes.
Main Results:
- Human papillomavirus (HPV) infection was identified in 77% of patients.
- HPV was associated with vulvar vestibulitis syndrome and essential/dysaesthetic vulvodynia.
- Interferon-alpha-2b showed a 58% cure rate for HPV-related vulvodynia, with 38% of patients experiencing persistent symptoms.
Conclusions:
- Vulvodynia is a multifactorial condition requiring evolving management strategies.
- Subclinical HPV infection is a significant factor, but treatment outcomes vary.
- Patients with persistent vulvodynia should be managed supportively, as a complete cure is not always achievable.
